SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1501>>A simply amazing launch given only about 100 salespeople.<< 100 pWard Knutson-5/25/2004
1500Looking at those Aloxi numbers, my guess is that my $140m 2004 sales prediction Biomaven-5/25/2004
1499The slides from the BofA presentation are on the Home Page. The weekly Aloxi salseminole-5/21/2004
1498MGI Pharma "outperform" Thursday, May 20, 2004 10:14:26 AM ET Robert Icebrg-5/21/2004
1497MGI Pharma "market outperform" Tuesday, May 18, 2004 1:07:25 PM ET JMIcebrg-5/18/2004
1496<i>Widely used anti-nausea drug may interfere with cancer chemotherapy MaBiomaven-5/5/2004
1495MGI Pharma's Aloxi Drug Sales Seen Strong 04.16.04, 11:11 AM ET Banc of Biomaven-4/16/2004
1494MGI Pharma "market outperform," target price raised Thursday, April 1Icebrg-4/15/2004
149370,000 unit demand in March. Simply OUTSTANDING launch. My projections are goiWard Knutson-4/14/2004
1492<i>March, 11, 2004 - Well I only got one taker for my Aloxi 2004 sales preBiomaven-4/14/2004
1491MethylGene Inc.: Further Preclinical Evidence of Synergy and Molecular Activity Icebrg-3/29/2004
1490Aloxi Injection 2004 Sales Results Expected to Exceed Previous Guidance WednesdaIcebrg-3/17/2004
1489Well I only got one taker for my Aloxi 2004 sales prediction contest - Ward, witBiomaven-3/11/2004
1488NCCN identified Aloxi injection as the "preferred" agent for the preveseminole-3/11/2004
1487This is the part of the report that I like. "Based on Feb. IMS data, 45,000seminole-3/11/2004
1486ML upgrade. New target price 61 USD Message 19903372Icebrg-3/11/2004
1485So February run-rate is already $86m/yr. If we assume continued straight-line Biomaven-3/10/2004
1484It looks like the company and the sales force were well prepared for the Aloxi rseminole-3/10/2004
1483Aloxi trends (monthly end user demand) as compiled by IMS: December 15,000 JanuWard Knutson-3/10/2004
1482Dr. Cancerblogger notes the following: oncologynews.info <i>Oncologists Icebrg-3/6/2004
1481Prostate. 2004 Apr 1;59(1):22-32. Links Antitumor activity of irofulven monothIcebrg-3/4/2004
1480very attractive indeed.tom pope-2/26/2004
1479MGI PHARMA Prices Private Placement of Convertible Notes Thursday February 26, 7Icebrg-2/26/2004
1478don't disagree, but the market reaction to this sort of thing is seldom favotom pope-2/25/2004
1477This is a "Bomb"? The exact opposite in my book, cash injected into tWard Knutson-2/25/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News